Use of pasteurized eckmann bacteria for treatment of metabolic disorders

• Main Authors: BELZER CLARA, CANI PATRICE, EVERARD AMANDINE, DURAERT CHRISTOPHE, DE VOS WILLEM, PLOVIER HENDRIK
• Format: Patent
• Language: Chinese; English
• Published: 05.04.2022
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES; VINEGAR; WINE

The present invention relates to the use of pasteurized Akkermann bacteria for the treatment of metabolic disorders. In particular, the present invention relates to pasteurized Akkermania muciniphila or fragments thereof for use in the treatment of a metabolic disorder in a subject in need thereof. The invention also relates to compositions, pharmaceutical compositions and medicaments comprising pasteurized Akkermania muciniphila or fragments thereof for use in the treatment of metabolic disorders. The present invention also relates to the use of pasteurized Akkermania muciniphila or fragments thereof for promoting weight loss in a subject in need thereof. 本发明涉及经巴氏灭菌的艾克曼菌用于治疗代谢病症的用途。特别地，本发明涉及用于治疗有需要的受试者的代谢病症的经巴氏灭菌的嗜粘蛋白艾克曼菌或其片段。本发明还涉及用于治疗代谢病症的包含经巴氏灭菌的嗜粘蛋白艾克曼菌或其片段的组合物、药物组合物和药物。本发明还涉及经巴氏灭菌的嗜粘蛋白艾克曼菌或其片段用于促进有需要的受试者的体重减轻的用途。